_id

690f341dccc777a4e85d1646

Ticker

BEAM

Name

Beam Therapeutics Inc

Exchange

NASDAQ

Address

238 Main Street, Cambridge, MA, United States, 02142

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://beamtx.com

Description

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, and BEAM-104, a cell therapy for development in sickle cell disease and beta-thalassemia; and BEAM-201 and other potential ex vivo CAR-T therapies. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

Last Close

27.51

Volume

1367976

Current Price

27.36

Change

-0.5452562704471179

Last Updated

2025-11-28T12:48:22.398Z

Image

data:image/webp;base64,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

Ipo Date

2020-02-06T00:00:00.000Z

Market Cap

2539917824

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9571192307692308

Sentiment Sources

26

Rating

4.4118

Target Price

45.9286

Strong Buy

10

Buy

4

Hold

3

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

9698000

Cost Of Revenue

109769000

Gross Profit

-100071000

Operating Expenses

26740000

Operating Income

-126811000

Interest Expense

10903000

Pretax Income

-112728000

Net Income

-112728000

Eps

-1.0990262228721408

Dividends Per Share

-

Shares Outstanding

101474944

Income Tax Expense

-

EBITDA

-107168000

Operating Margin

-1307.599505052588

Total Other Income Expense Net

14083000

Cash

267959999

Short Term Investments

807010000

Receivables

-

Inventories

-

Total Current Assets

1098547000

Property Plant Equipment

205285000

Total Assets

1311081000

Payables

9545000

Short Term Debt

12688000

Long Term Debt

-

Total Liabilities

345079000

Equity

966002000

Depreciation

5560000

Change In Working Capital

-7124000

Cash From Operations

-81479000

Capital Expenditures

5011000

Cash From Investing

65655000

Cash From Financing

1675000

Net Change In Cash

-14172001

PE

-

PB

2.9051048707559612

ROE

-11.669541056850814

ROA

-8.598095769826578

FCF

-86490000

Fcf Percent

-8.918333677046814

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

3.5

Growth Investing Score

2

Momentum Investing Score

4

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

9698000

Quarters > 0 > income Statement > cost Of Revenue

109769000

Quarters > 0 > income Statement > gross Profit

-100071000

Quarters > 0 > income Statement > operating Expenses

26740000

Quarters > 0 > income Statement > operating Income

-126811000

Quarters > 0 > income Statement > interest Expense

10903000

Quarters > 0 > income Statement > pretax Income

-112728000

Quarters > 0 > income Statement > net Income

-112728000

Quarters > 0 > income Statement > eps

-1.0990262228721408

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

102570801

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-107168000

Quarters > 0 > income Statement > operating Margin

-1307.599505052588

Quarters > 0 > income Statement > total Other Income Expense Net

14083000

Quarters > 0 > balance Sheet > cash

267959999

Quarters > 0 > balance Sheet > short Term Investments

807010000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

1098547000

Quarters > 0 > balance Sheet > property Plant Equipment

205285000

Quarters > 0 > balance Sheet > total Assets

1311081000

Quarters > 0 > balance Sheet > payables

9545000

Quarters > 0 > balance Sheet > short Term Debt

12688000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

345079000

Quarters > 0 > balance Sheet > equity

966002000

Quarters > 0 > cash Flow > net Income

-112728000

Quarters > 0 > cash Flow > depreciation

5560000

Quarters > 0 > cash Flow > change In Working Capital

-7124000

Quarters > 0 > cash Flow > cash From Operations

-81479000

Quarters > 0 > cash Flow > capital Expenditures

5011000

Quarters > 0 > cash Flow > cash From Investing

65655000

Quarters > 0 > cash Flow > cash From Financing

1675000

Quarters > 0 > cash Flow > net Change In Cash

-14172001

Quarters > 0 > ratios > PE

-1.0990262228721408

Quarters > 0 > ratios > PB

2.9051048707559612

Quarters > 0 > ratios > ROE

-11.669541056850814

Quarters > 0 > ratios > ROA

-8.598095769826578

Quarters > 0 > ratios > FCF

-86490000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-8.918333677046814

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

8466000

Quarters > 1 > income Statement > cost Of Revenue

101758000

Quarters > 1 > income Statement > gross Profit

-93292000

Quarters > 1 > income Statement > operating Expenses

26859000

Quarters > 1 > income Statement > operating Income

-120151000

Quarters > 1 > income Statement > interest Expense

12326000

Quarters > 1 > income Statement > pretax Income

-102291000

Quarters > 1 > income Statement > net Income

-102291000

Quarters > 1 > income Statement > eps

-1.0029002938021074

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

101995184

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-114613000

Quarters > 1 > income Statement > operating Margin

-1419.2180486652494

Quarters > 1 > income Statement > total Other Income Expense Net

17860000

Quarters > 1 > balance Sheet > cash

282132000

Quarters > 1 > balance Sheet > short Term Investments

868205000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

1175464000

Quarters > 1 > balance Sheet > property Plant Equipment

208392000

Quarters > 1 > balance Sheet > total Assets

1391157000

Quarters > 1 > balance Sheet > payables

10556000

Quarters > 1 > balance Sheet > short Term Debt

12949000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

344344000

Quarters > 1 > balance Sheet > equity

1046813000

Quarters > 1 > cash Flow > net Income

-102291000

Quarters > 1 > cash Flow > depreciation

5538000

Quarters > 1 > cash Flow > change In Working Capital

3440000

Quarters > 1 > cash Flow > cash From Operations

-76450000

Quarters > 1 > cash Flow > capital Expenditures

3136000

Quarters > 1 > cash Flow > cash From Investing

-170411000

Quarters > 1 > cash Flow > cash From Financing

1109000

Quarters > 1 > cash Flow > net Change In Cash

-245752000

Quarters > 1 > ratios > PE

-1.0029002938021074

Quarters > 1 > ratios > PB

2.6657944009484025

Quarters > 1 > ratios > ROE

-9.77165931259929

Quarters > 1 > ratios > ROA

-7.35294434776233

Quarters > 1 > ratios > FCF

-79586000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-9.40066146940704

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

7470000

Quarters > 2 > income Statement > cost Of Revenue

98816000

Quarters > 2 > income Statement > gross Profit

-91346000

Quarters > 2 > income Statement > operating Expenses

27940000

Quarters > 2 > income Statement > operating Income

-119286000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-109270000

Quarters > 2 > income Statement > net Income

-109270000

Quarters > 2 > income Statement > eps

-1.2420574026712135

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

87975000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-113758000

Quarters > 2 > income Statement > operating Margin

-1596.867469879518

Quarters > 2 > income Statement > total Other Income Expense Net

10016000

Quarters > 2 > balance Sheet > cash

527907000

Quarters > 2 > balance Sheet > short Term Investments

692045000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

1247614000

Quarters > 2 > balance Sheet > property Plant Equipment

211785000

Quarters > 2 > balance Sheet > total Assets

1466920000

Quarters > 2 > balance Sheet > payables

7699000

Quarters > 2 > balance Sheet > short Term Debt

13210000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

343784000

Quarters > 2 > balance Sheet > equity

1123136000

Quarters > 2 > cash Flow > net Income

-109270000

Quarters > 2 > cash Flow > depreciation

5528000

Quarters > 2 > cash Flow > change In Working Capital

-25472000

Quarters > 2 > cash Flow > cash From Operations

-103884000

Quarters > 2 > cash Flow > capital Expenditures

3065000

Quarters > 2 > cash Flow > cash From Investing

-125089000

Quarters > 2 > cash Flow > cash From Financing

473379000

Quarters > 2 > cash Flow > net Change In Cash

244406000

Quarters > 2 > ratios > PE

-1.2420574026712135

Quarters > 2 > ratios > PB

2.143102883355177

Quarters > 2 > ratios > ROE

-9.729008775428799

Quarters > 2 > ratios > ROA

-7.4489406375262455

Quarters > 2 > ratios > FCF

-106949000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-14.317135207496653

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

30067000

Quarters > 3 > income Statement > cost Of Revenue

101444000

Quarters > 3 > income Statement > gross Profit

-71377000

Quarters > 3 > income Statement > operating Expenses

28660000

Quarters > 3 > income Statement > operating Income

-100037000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-90354000

Quarters > 3 > income Statement > net Income

-90354000

Quarters > 3 > income Statement > eps

-1.0909136877237655

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

82824151

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-94594000

Quarters > 3 > income Statement > operating Margin

-332.71360627930954

Quarters > 3 > income Statement > total Other Income Expense Net

9683000

Quarters > 3 > balance Sheet > cash

281967000

Quarters > 3 > balance Sheet > short Term Investments

568773000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

878149000

Quarters > 3 > balance Sheet > property Plant Equipment

216277000

Quarters > 3 > balance Sheet > total Assets

1103824000

Quarters > 3 > balance Sheet > payables

3871000

Quarters > 3 > balance Sheet > short Term Debt

13469000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

370279000

Quarters > 3 > balance Sheet > equity

733545000

Quarters > 3 > cash Flow > net Income

-90354000

Quarters > 3 > cash Flow > depreciation

15111000

Quarters > 3 > cash Flow > change In Working Capital

-20752000

Quarters > 3 > cash Flow > cash From Operations

-76365000

Quarters > 3 > cash Flow > capital Expenditures

2970000

Quarters > 3 > cash Flow > cash From Investing

126280000

Quarters > 3 > cash Flow > cash From Financing

3444000

Quarters > 3 > cash Flow > net Change In Cash

53359000

Quarters > 3 > ratios > PE

-1.0909136877237655

Quarters > 3 > ratios > PB

3.089202123059935

Quarters > 3 > ratios > ROE

-12.317444737541663

Quarters > 3 > ratios > ROA

-8.185544072243403

Quarters > 3 > ratios > FCF

-79335000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-2.6386071107859115

Quarters > 3 > health Score

26

Valuation > metrics > PE

-1.0990262228721408

Valuation > metrics > PB

2.9051048707559612

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-11.669541056850814

Profitability > metrics > ROA

-10.26155458073255

Profitability > metrics > Net Margin

-11.623839967003505

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.35722389808716754

Risk > metrics > Interest Coverage

-11.630835549848666

Risk > final Score

13

Risk > verdict

High

Liquidity > metrics > Current Ratio

49.41065083434534

Liquidity > metrics > Quick Ratio

49.41065083434534

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

49.10797876940065

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

21

Prev Risks > 1

-46

Prev Risks > 2

-46

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:16:21.869Z